A detailed history of Landscape Capital Management, L.L.C. transactions in Exact Sciences Corp stock. As of the latest transaction made, Landscape Capital Management, L.L.C. holds 26,491 shares of EXAS stock, worth $1.52 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
26,491
Previous 24,226 9.35%
Holding current value
$1.52 Million
Previous $1.02 Million 76.25%
% of portfolio
0.2%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$42.43 - $70.83 $96,103 - $160,429
2,265 Added 9.35%
26,491 $1.8 Million
Q2 2024

Aug 12, 2024

BUY
$41.33 - $74.26 $1 Million - $1.8 Million
24,226 New
24,226 $1.02 Million
Q4 2023

Feb 05, 2024

BUY
$59.06 - $75.72 $203,343 - $260,703
3,443 New
3,443 $254,000
Q2 2022

Aug 05, 2022

BUY
$35.61 - $76.23 $167,509 - $358,585
4,704 Added 69.61%
11,462 $451,000
Q1 2022

May 11, 2022

BUY
$57.56 - $82.54 $147,929 - $212,127
2,570 Added 61.37%
6,758 $473,000
Q4 2021

Feb 01, 2022

SELL
$72.5 - $100.68 $5,075 - $7,047
-70 Reduced 1.64%
4,188 $326,000
Q3 2021

Nov 09, 2021

BUY
$90.24 - $124.05 $384,241 - $528,204
4,258 New
4,258 $406,000
Q2 2020

Aug 13, 2020

SELL
$55.75 - $92.75 $268,046 - $445,942
-4,808 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$37.9 - $104.44 $182,223 - $502,147
4,808 New
4,808 $279,000
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $993,196 - $1.46 Million
-17,723 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $616,904 - $1.03 Million
12,775 Added 258.19%
17,723 $1.4 Million
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $187,232 - $346,162
4,948 New
4,948 $296,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Landscape Capital Management, L.L.C. Portfolio

Follow Landscape Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.